Generics
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
13 April 2026 - Canadian pharmaceutical company Apotex Inc announced on Friday that its US subsidiary Apotex Corp has received the first US Food and Drug Administration (FDA) tentative approval for it...
DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules
10 April 2026 - DifGen Pharmaceuticals LLC, a US-based specialty generic pharmaceutical company, announced on Thursday that its Canadian partner, Apotex Inc, has received final approval from the US Fo...
Dexcel Pharma's Nintedanib Capsules approved for US launch
8 April 2026 - Dexcel Pharma USA, a subsidiary of Israeli pharmaceutical company Dexcel Pharma, announced on Tuesday that it has received final approval from the US Food and Drug Administration (FDA) ...
Upsher-Smith launches generic version of Ciprodex ear drop suspension
7 April 2026 - US pharmaceutical company Upsher-Smith Laboratories LLC, a subsidiary of Taiwan-based Bora Pharmaceuticals Co Ltd (TW:6472) (OTCQX:BORAY) announced on Monday the launch of Ciprofloxacin...
Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease
1 April 2026 - Veterinary pharmaceutical company Parnell Technologies Pty Ltd on Wednesday announced the US launch of nixiFLOR, an injectable solution approved by the US Food and Drug Administration (...
Samsung Bioepis partners with Sandoz on up to five next-generation biosimilars
18 March 2026 - South Korean biopharmaceutical company Samsung Bioepis Co Ltd on Wednesday announced a global development and commercialisation agreement with Sandoz Group AG (SIX:SDZ), a generics and...